| |
|
|
|
Evelo Biosciences Inc.  
|
|
9.42 1.19 (0.14%) |
06-21 16:00 |
|
Open: |
8.02 |
Pre close: |
8.23 |
Target:
|
11.21 
|
|
High: |
9.6 |
Low: |
8.02 |
Resistance:
|
9.60
11.21
|
|
Volume: |
74,606 |
Market Cap: |
302M |
Support:
|
7.57
6.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.41
|
MACD |
MACD(12,26):
|
0.17 |
|
MA(20): |
7.47 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
8.42 |
Stochastic Oscillator |
%K(14,3):
|
87.68 |
|
MA(250): |
10.35  |
%D(3): |
85.19 |
|
Average Volume(K) |
3-Month: |
2826
|
52-Week |
High:
|
15.89 |
|
10-Days: |
2607 |
Low: |
6.32 |
|
RSI |
RSI(14):
|
66.58 |
Change(%): |
-29.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.360 |
Return on Equity (ttm) |
-60.5 |
Shares Out. (M) |
32.04 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-32.4 |
Shares Float (M) |
11.79 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.68 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
85.20 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1620 |
|
Book Value (p.s.) |
3.710 |
EBITDA (p.s.) |
-2.084 |
P/E |
-3.99 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-56.96 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-40.36 |
P/CF |
-5.30 |
|
|
|
|
|
|
